Research Focus

Former Employee. Human Oncology & Pathogenesis Pgm; Intern

Recent additions – View all

1. Evaluation of tagraxofusp (SL-401) alone and in combination with ruxolitinib for the treatment of myeloproliferative neoplasms

   Meeting Abstract

   Krishnan, A.; Pagane, M.; Roshal, M.; McGovern, E.; Stone-Molloy, Z.; Chen, J.; Brooks, C.; Levine, R. L.; Rampal, R. K.
   Blood (2019)

   Fulltext@MSK | Save
2. Evaluation of combination tagraxofusp (SL-401) and hypomethylating agent (HMA) therapy for the treatment of chronic myelomonocytic leukemia (CMML)

   Meeting Abstract

   Krishnan, A.; Li, B.; Pagane, M.; McGovern, E.; Stone-Molloy, Z.; Chen, J.; Brooks, C.; Levine, R. L.; Rampal, R. K.
   Blood (2018)

   Fulltext@MSK | Save